FOX8 Cleveland

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection

WEST LAFAYETTE, Ind., Nov. 16, 2023 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate ...
NBC4 Columbus

On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board

WEST LAFAYETTE, Ind., Jan. 3, 2024 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate ...
ksn.com

On Target Laboratories Granted New Technology Add-On Payment (NTAP) for CYTALUX® (pafolacianine) injection in Ovarian and Lung Cancer Indications

WEST LAFAYETTE, Ind., Aug. 10, 2023 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate ...
Fox 5 San Diego

On Target Laboratories Founder Philip Low Receives Legacy Award from the American Lung Association

Founder and Purdue University researcher Philip Low to be recognized for his invention of CYTALUX, a fluorescent targeted molecule that illuminates lung cancer cells during surgery Dr. Low invented ...
Purdue University

New Purdue Research Park-based firm helps surgeons see cancer cells

On Target Laboratories LLC is developing probes to illuminate cancer cells, which may help surgeons see more of them during surgery. On Target Laboratories has become a tenant of the Purdue Research ...